XML 44 R33.htm IDEA: XBRL DOCUMENT
v3.22.1

Stockholders' Equity (Details) - USD ($) |  |  |  |  |  |  |  |  | 1 Months Ended | 12 Months Ended |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Dec. 09, 2021 | Oct. 01, 2021 | Jul. 12, 2021 | Jan. 06, 2021 | Dec. 16, 2020 | May 15, 2020 | Apr. 27, 2020 | Apr. 01, 2020 | Dec. 31, 2021 | Dec. 22, 2021 | Dec. 17, 2021 | Sep. 30, 2021 | Jul. 16, 2021 | Jun. 25, 2021 | Jun. 18, 2021 | Feb. 18, 2021 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 08, 2021 | May 31, 2021 | Dec. 31, 2014
Stockholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock issued (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 42,475 |  |  |
Shares issued for cashless exercise of warrants (in Shares) |  |  |  |  |  |  |  |  | 0 |  |  |  |  |  |  |  | 0 | 60,513 |  |  |
Exercise of warrants (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 2,628,061 | $ 8,056,416 |  |  |
Shares of common stock (in Shares) |  |  |  |  |  |  |  |  | 0 |  |  |  |  |  |  |  | 0 | 90,204 | 8,823,530 |  |
Issued of common stock (in Shares) |  |  |  |  |  |  |  |  | 27,740,147 |  |  |  |  |  |  |  | 27,740,147 | 16,332,939 |  |  |
Net cash proceeds (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 161,226,945 |  |  |  |
Common stock, par value (in Dollars per share) |  |  |  |  |  |  |  |  | $ 0.001 |  |  |  |  |  |  |  | $ 0.001 | $ 0.001 | $ 0.001 |  |
Price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 17 |  |
Underwriters granted period | 30 days |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Additional shares of common stock (in Shares) | 1,323,529 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Granting of common stock awards (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,152,942
Granting to option or stock awards (in Dollars) |  |  |  |  |  |  |  |  | $ 6,652,942 |  |  |  |  |  |  |  | $ 6,652,942 |  |  | $ 1,500,000 |
Stock options exercisable period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 10 years |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4 years |  |  |  |
Issued shares (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,900,000 |  |  |  |
Options for shares (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,821,118 |  |  |  |
Options awarded (in Shares) |  |  |  |  |  |  |  |  |  | 65,000 |  |  |  |  |  |  |  |  |  |  |
Exercise price (in Dollars per share) |  |  |  |  |  |  |  |  |  | $ 21.11 |  |  |  |  |  |  |  |  |  |  |
Term |  |  |  |  |  |  |  |  |  | 10 years |  |  |  |  |  |  |  |  |  |  |
Expected life term |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 6 years 3 months |  |  |
Expected dividends rate |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% | 0.00% |  |  |
Shareholder approval shares (in Shares) |  |  |  |  |  |  |  |  |  |  | 3,821,118 |  |  |  |  |  |  |  |  |  |
Stock options, description |  |  |  |  |  |  |  |  |  |  |  | As of December 31, 2021, six performance metrics for 520,000 options were met. Vesting of such options is subject to the passage of time. At December 31, 2021, the Company incurred expense of $3,392,419 related to these options.During the year ended December 31, 2020, the Company awarded a total of 1,000,000 options to employees with exercise prices ranging from $28.00- $45.61 and a 10-year term vesting over 4-year period. The options have an aggregate fair value of $32.4 million calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include: (1) discount rate of 0.36%-0.83% (2) expected life of 6.25 years, (3) expected volatility of 101%-108%, and (4) zero expected dividends. During the year ended December 31, 2020, the Company recognized additional compensation expense of approximately $1,500,000 related to acceleration of vesting and a nominal amount related to the modification of certain options in connection with the separation and settlement agreement with Dr. Ottavio Vitolo (see note 10). During the year ended December 31, 2020, the Company recognized compensation expense of approximately $484,000 related to the extended period of time to allow for some options to vest under the separation and settlement agreement with Dr. Thomas Wessel. This was considered a Type III modification and as a result the total expense of $1.8 million previously recognized was reversed as the options would not have vested prior to the modification (see note 10). A summary of the changes in options outstanding for the years ended December 31, 2021 and 2020 is as follows: Number of Shares Weighted Average Exercise Price Per Share Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding and expected to vest at December 31, 2019 3,615,602 $19.96 9.2 $74,837,043 Granted 1,000,000 39.50 9.3 - Exercised (253,927) - - - Forfeited (455,938) - - - Outstanding and expected to vest at December 31, 2020 3,905,737 $24.32 8.4 $48,952,339 Granted 7,057,004 21.15 9.8 - Exercised (174,619) - - - Forfeited (457,500) - - - Outstanding and expected to vest at December 31, 2021 10,330,622 $22.52 9.0 $46,088,534 Options exercisable at December 31, 2021 2,140,490 $20.99 7.3 $19,511,463 At December 31, 2021, the Company has unrecognized stock-based compensation expense of approximately $143,200,000 related to unvested stock options over the weighted average remaining service period of 2.94 years. The weighted average fair value of options granted during the years ended December 31, 2021 and 2020 was approximately $22.15 and $32.45 per share, respectively, on the date of grant using the Black-Scholes option pricing model with the following assumptions: Years Ended Years Ended December 31, December 31, 2021 2020 Risk free interest rate 0.59 to 1.31% 0.36 to 0.83% Dividend yield 0% 0% Volatility 97-101 % 101-108% Expected term (in years) 5 to 6.25 6.25 Warrants A summary of the changes in outstanding warrants during the years ended December 31, 2021 and 2020 is as follows: Number of Shares Weighted Average Exercise Price Per Share Outstanding at December 31, 2019 3,646,870 $6.83 Issued 250,000 $33.32 Exercised (1,211,199) $7.27 Forfeited/Expired (15,040) $16.80 Outstanding at December 31, 2020 2,670,633 $9.11 Issued 972,000 $31.98 Exercised (433,856) $6.06 Outstanding at December 31, 2021 3,208,777 $16.45 Warrants exercisable at December 31, 2021 2,767,246 $13.92 On October 1, 2021, the Company awarded a total of 42,000 warrants to a consultant with an exercise price of $26.74 and a 10-year term, vesting 25% after year one and 6.25% quarterly there after until 100% vested. The warrants have an aggregate fair value of $891,265 calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include: (1) discount rate of 1.10% (2) expected life of 6.25 years, (3) expected volatility of 99%, and (4) zero expected dividends. On July 16, 2021, the Company awarded a total of 500,000 warrants to Arbormentis, LLC with an exercise price of $31.17 and a 7-year term, vesting immediately. The warrants have an aggregate fair value of $10,241,599 calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include: (1) discount rate of 0.48% (2) expected life of 3.50 years, (3) expected volatility of 101%, and (4) zero expected dividends. On July 12, 2021, the Company awarded a total of 10,000 warrants to a consultant with an exercise price of $34.77 and a 5-year term, vesting over a 1-year period. The warrants granted are time-based vesting. The warrants have an aggregate fair value of $212,219 calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include: (1) discount rate of 0.43% (2) expected life of 3.00 years, (3) expected volatility of 99%, and (4) zero expected dividends. On June 25, 2021, the Company awarded a total of 10,000 warrants to a consultant with an exercise price of $34.35 and a 5-year term, vesting over a 1-year period. The warrants granted are time-based vesting. The warrants have an aggregate fair value of $211,653 calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include: (1) discount rate of 0.43% (2) expected life of 3.00 years, (3) expected volatility of 100%, and (4) zero expected dividends. On June 18, 2021, the Company awarded a total of 10,000 warrants to a consultant with an exercise price of $30.90 and a 5-year term, vesting over a 1-year period. The warrants granted are time-based vesting. The warrants have an aggregate fair value of $190,401 calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include: (1) discount rate of 0.47% (2) expected life of 3.00 years, (3) expected volatility of 100%, and (4) zero expected dividends. On January 6, 2021, the Company awarded a total of 400,000 warrants to consultants with an exercise price of $33.43 and a 10-year term, vesting over 4-year period. The warrants granted include time-based vesting grants and performance vesting based on the Company’s achievement of performance metrics. The warrants have an aggregate fair value of $10.6 million calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include: (1) discount rate of 0.59% (2) expected life of 6.25 years, (3) expected volatility of 101%, and (4) zero expected dividends. As of December 31, 2021, six performance metrics for 200,000 warrants were met. Vesting of such options is subject to the passage of time. |  |  |  |  |  |  |  |  |
Description of employees options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | The options have an aggregate fair value of $32.4 million calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include: (1) discount rate of 0.36%-0.83% (2) expected life of 6.25 years, (3) expected volatility of 101%-108%, and (4) zero expected dividends. |  |  |
Additional compensation expense (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 40,494,476 | $ 20,777,272 |  |  |
Recognized compensation expense (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 484,000 |  |  |
Total expense (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,800,000 |  |  |
Unrecognized stock-based compensation expense (in Dollars) |  |  |  |  |  |  |  |  | $ 12,400,000 |  |  |  |  |  |  |  | $ 12,400,000 |  |  |  |
Weighted average remaining service period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 years 11 months 8 days |  |  |  |
Number of granted warrants (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 7,057,004 | 1,000,000 |  |  |
Performance metrics, description |  |  |  |  |  |  |  |  | As of December 31, 2021, six performance metrics for 200,000 warrants were met. |  |  |  |  |  |  |  |  |  |  |  |
Incurred expense (in Dollars) |  |  |  |  |  |  |  |  | $ 1,304,776 |  |  |  |  |  |  |  | $ 1,304,776 |  |  |  |
Aggregate intrinsic value of warrants vested and outstanding (in Dollars) |  |  |  |  |  |  |  |  | 31,300,000 |  |  |  |  |  |  |  | 31,300,000 |  |  |  |
Stock Based Compensation [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Additional compensation expense (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,500,000 |  |  |
Unrecognized stock-based compensation expense (in Dollars) |  |  |  |  |  |  |  |  | $ 143,200,000 |  |  |  |  |  |  |  | $ 143,200,000 |  |  |  |
Jefferies LLC [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate of offering price (in Dollars) |  |  |  |  |  | $ 75,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Black-Scholes Option Pricing Model [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate fair value of options (in Dollars) |  |  |  | $ 39,700,000 |  |  |  |  |  | $ 1,100,000 |  |  |  |  |  | $ 701,000 |  |  |  |  |
Discount rate |  |  |  | 0.59% |  |  |  |  |  |  |  |  |  |  |  | 0.75% |  |  |  |  |
Expected life term |  |  |  | 6 years 3 months |  |  |  |  |  |  |  |  |  |  |  | 6 years 3 months |  |  |  |  |
Expected volatility rate |  |  |  | 101.00% |  |  |  |  |  |  |  |  |  |  |  | 101.00% |  |  |  |  |
Expected dividends rate |  |  |  | 0.00% |  |  |  |  |  | 0.00% |  |  |  |  |  | 0.00% |  |  |  |  |
Consultants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate fair value of options (in Dollars) |  | $ 891,265 | $ 212,219 | $ 10,600,000 | $ 2,860,000 |  |  | $ 2,500,000 |  |  |  |  |  | $ 211,653 | $ 190,401 |  |  |  |  |  |
Discount rate |  | 1.10% | 0.43% | 0.59% | 0.37% |  |  | 0.26% |  |  |  |  |  | 0.43% | 0.47% |  |  |  |  |  |
Expected life term |  | 6 years 3 months | 3 years | 6 years 3 months | 5 years |  |  | 2 years 6 months |  |  |  |  |  | 3 years | 3 years |  |  |  |  |  |
Expected volatility rate |  | 99.00% | 99.00% | 101.00% | 105.00% |  |  | 118.00% |  |  |  |  |  | 100.00% | 100.00% |  |  |  |  |  |
Expected dividends rate |  | 0.00% | 0.00% | 0.00% | 0.00% |  |  | 0.00% |  |  |  |  |  | 0.00% | 0.00% |  |  |  |  |  |
Number of granted warrants (in Shares) |  | 42,000 | 10,000 | 400,000 | 108,000 |  |  | 120,000 |  |  |  |  |  | 10,000 | 10,000 |  |  |  |  |  |
Exercise price per share (in Dollars per share) |  | $ 26.74 | $ 34.77 | $ 33.43 | $ 34.87 |  |  | $ 31.59 |  |  |  |  |  | $ 34.35 | $ 30.9 |  |  |  |  |  |
Term year |  | 10 years | 5 years | 10 years | 5 years |  |  | 5 years |  |  |  |  |  | 5 years | 5 years |  |  |  |  |  |
Vesting period |  |  | 1 year | 4 years |  |  |  |  |  |  |  |  |  | 1 year | 1 year |  |  |  |  |  |
Arbormentis, LLC [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate fair value of options (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  | $ 10,241,599 |  |  |  |  |  |  |  |
Discount rate |  |  |  |  |  |  |  |  |  |  |  |  | 0.48% |  |  |  |  |  |  |  |
Expected life term |  |  |  |  |  |  |  |  |  |  |  |  | 3 years 6 months |  |  |  |  |  |  |  |
Expected volatility rate |  |  |  |  |  |  |  |  |  |  |  |  | 101.00% |  |  |  |  |  |  |  |
Expected dividends rate |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% |  |  |  |  |  |  |  |
Number of granted warrants (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  | 500,000 |  |  |  |  |  |  |  |
Exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  |  | $ 31.17 |  |  |  |  |  |  |  |
Term year |  |  |  |  |  |  |  |  |  |  |  |  | 7 years |  |  |  |  |  |  |  |
Consultant One [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate fair value of options (in Dollars) |  |  |  |  | $ 479,000 |  | $ 48,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Discount rate |  |  |  |  | 0.37% |  | 0.27% |  |  |  |  |  |  |  |  |  |  |  |  |  |
Expected life term |  |  |  |  | 3 years 9 months |  | 2 years 6 months |  |  |  |  |  |  |  |  |  |  |  |  |  |
Expected volatility rate |  |  |  |  | 105.00% |  | 116.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |
Expected dividends rate |  |  |  |  | 0.00% |  | 0.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of granted warrants (in Shares) |  |  |  |  | 20,000 |  | 2,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price per share (in Dollars per share) |  |  |  |  | $ 34.87 |  | $ 37.67 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term year |  |  |  |  | 5 years |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  | 4 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Underwriters [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 15.98 |  |
Stock Options [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  | 4 years |  |  |  |  |  |  |  |  |  |  |  | 4 years |  |  |  |  |
Options awarded (in Shares) |  |  |  | 1,490,000 |  |  |  |  |  |  |  |  |  |  |  | 25,000 |  |  |  |  |
Exercise price (in Dollars per share) |  |  |  | $ 33.43 |  |  |  |  |  |  |  |  |  |  |  | $ 35.15 |  |  |  |  |
Term |  |  |  | 10 years |  |  |  |  |  |  |  |  |  |  |  | 10 years |  |  |  |  |
Vesting Period Four [Member] | Black-Scholes Option Pricing Model [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Expected dividends rate |  |  |  |  |  |  |  |  |  |  | 0.00% |  |  |  |  |  |  |  |  |  |
Minimum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  | 1 year |  |  |  |  |  |  |  |  |  |  |
Discount rate |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.59% | 0.36% |  |  |
Expected life term |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5 years |  |  |  |
Expected volatility rate |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 97.00% | 101.00% |  |  |
Minimum [Member] | Black-Scholes Option Pricing Model [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Discount rate |  |  |  |  |  |  |  |  |  | 1.23% |  |  |  |  |  |  |  |  |  |  |
Expected life term |  |  |  |  |  |  |  |  |  | 5 years 6 months |  |  |  |  |  |  |  |  |  |  |
Expected volatility rate |  |  |  |  |  |  |  |  |  | 96.00% |  |  |  |  |  |  |  |  |  |  |
Minimum [Member] | Vesting Period One to Four [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Expected life term |  |  |  |  |  |  |  |  |  |  | 5 years 2 months 12 days |  |  |  |  |  |  |  |  |  |
Expected volatility rate |  |  |  |  |  |  |  |  |  |  | 97.00% |  |  |  |  |  |  |  |  |  |
Minimum [Member] | Vesting Period One to Four [Member] | Black-Scholes Option Pricing Model [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Discount rate |  |  |  |  |  |  |  |  |  |  | 1.18% |  |  |  |  |  |  |  |  |  |
Maximum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  | 4 years |  |  |  |  |  |  |  |  |  |  |
Discount rate |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1.31% | 0.83% |  |  |
Expected life term |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 6 years 3 months |  |  |  |
Expected volatility rate |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 101.00% | 108.00% |  |  |
Maximum [Member] | Black-Scholes Option Pricing Model [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Discount rate |  |  |  |  |  |  |  |  |  | 1.31% |  |  |  |  |  |  |  |  |  |  |
Expected life term |  |  |  |  |  |  |  |  |  | 6 years 3 months |  |  |  |  |  |  |  |  |  |  |
Expected volatility rate |  |  |  |  |  |  |  |  |  | 98.00% |  |  |  |  |  |  |  |  |  |  |
Maximum [Member] | Vesting Period One to Four [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  | 1 year |  |  |  |  |  |  |  |  |  |
Expected life term |  |  |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |
Maximum [Member] | Vesting Period One to Four [Member] | Black-Scholes Option Pricing Model [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate fair value of options (in Dollars) |  |  |  |  |  |  |  |  |  |  | $ 81.6 |  |  |  |  |  |  |  |  |  |
Discount rate |  |  |  |  |  |  |  |  |  |  | 1.26% |  |  |  |  |  |  |  |  |  |
Expected volatility rate |  |  |  |  |  |  |  |  |  |  | 99.00% |  |  |  |  |  |  |  |  |  |
Maximum [Member] | Vesting Period One to Four [Member] | Stock Options [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  |  |  |  | 4 years |  |  |  |  |  |  |  |  |  |
Options awarded (in Shares) |  |  |  |  |  |  |  |  |  |  | 5,477,004 |  |  |  |  |  |  |  |  |  |
Exercise price (in Dollars per share) |  |  |  |  |  |  |  |  |  |  | $ 19.03 |  |  |  |  |  |  |  |  |  |
Term |  |  |  |  |  |  |  |  |  |  | 10 years |  |  |  |  |  |  |  |  |  |
Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock issued (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 433,856 | 1,159,989 |  |  |
Shares of common stock (in Shares) |  |  |  |  |  |  |  |  | 174,619 |  |  |  |  |  |  |  | 174,619 | 155,558 |  |  |
Issued of common stock (in Shares) |  |  |  |  |  |  |  |  | 0 |  |  |  |  |  |  |  | 0 | 98,370 |  |  |
Exercised common shares issued (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 668,431 | 735,514 |  |  |
Additional compensation expense (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock [Member] | Jefferies LLC [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares of common stock (in Shares) |  |  |  |  |  |  |  |  | 651,674 |  |  |  |  |  |  |  | 651,674 | 427,700 |  |  |
Net cash proceeds (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 23,416,036 | $ 19,791,644 |  |  |

X
- Definition Total number of additional shares of common stock. + References No definition available. + Details
Name: | rlmd_AdditionalSharesOfCommonStock
Namespace Prefix: | rlmd_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. + References No definition available. + Details
Name: | rlmd_AggregateIntrinsicValueOfWarrantsVestedAndOutstanding
Namespace Prefix: | rlmd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Value of cashless exercise of warrants. + References No definition available. + Details
Name: | rlmd_CashlessExerciseOfWarrantsValue
Namespace Prefix: | rlmd_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References No definition available. + Details
Name: | rlmd_ClassOfWarrantsOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | rlmd_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Description of Employees Options. + References No definition available. + Details
Name: | rlmd_DescriptionOfEmployeesOptions
Namespace Prefix: | rlmd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercised common shares Issued. + References No definition available. + Details
Name: | rlmd_ExercisedCommonSharesIssued
Namespace Prefix: | rlmd_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | rlmd_GrantingOfCommonStockAwards
Namespace Prefix: | rlmd_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Granting to option or stock awards. + References No definition available. + Details
Name: | rlmd_GrantingToOptionOrStockAwards
Namespace Prefix: | rlmd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of Incurred Expense. + References No definition available. + Details
Name: | rlmd_IncurredExpense
Namespace Prefix: | rlmd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Description for performance metrics. + References No definition available. + Details
Name: | rlmd_PerformanceMetricsDescription
Namespace Prefix: | rlmd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Recognized compensation expense. + References No definition available. + Details
Name: | rlmd_RecognizedCompensationExpense
Namespace Prefix: | rlmd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | rlmd_ShareholderApprovalShares
Namespace Prefix: | rlmd_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Stock options exercisable Period. + References No definition available. + Details
Name: | rlmd_StockOptionsExercisablePeriod
Namespace Prefix: | rlmd_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | rlmd_StockholdersEquityDetailsLineItems
Namespace Prefix: | rlmd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | rlmd_TermYear
Namespace Prefix: | rlmd_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | rlmd_VastingPeriod
Namespace Prefix: | rlmd_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of increase (decrease) to additional paid-in capital (APIC) for recognition and exercise of award under share-based payment arrangement. + References No definition available. + Details
Name: | us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of cost to be recognized for option under share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of excess stock shares of an entity that have been sold or granted to shareholders. + References No definition available. + Details
Name: | us-gaap_ExcessStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585 + Details
Name: | us-gaap_OtherNoncashIncomeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromDebtNetOfIssuanceCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation. + References No definition available. + Details
Name: | us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(iii) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(ii) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The risk-free interest rate assumption that is used in valuing an option on its own shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(iv) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Gross number of share options (or share units) granted during the period. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(i) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14.D.2) -URI http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644 + Details
Name: | us-gaap_SharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. + References No definition available. + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesIssuedForServices
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Value of stock issued pursuant to acquisitions during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29-31) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodValueAcquisitions
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644 + Details
Name: | us-gaap_StockOptionExercisePriceIncrease
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rlmd_JefferiesLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rlmd_BlackScholesOptionPricingModelMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rlmd_ConsultantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rlmd_ArbormentisLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rlmd_ConsultantOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=rlmd_UnderwritersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=rlmd_StockOptionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_VestingAxis=rlmd_VestingPeriodFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_VestingAxis=rlmd_VestingPeriodOneToFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |